Q3 2014
Released Oct 31, 2014, after the close
10-Q filed Oct 31, 2014, 31 days after period end · 0001237831-14-000048
Q3 2014 · 10-Q
Revenue$117.79M$117.79M +9.9% vs Q3 2013+3.7% vs Q2 2014
Net Income$23.06M$23.06M +13.5% vs Q3 2013+11.7% vs Q2 2014
EPS Diluted$0.24$0.24 +9.1% vs Q3 2013+9.1% vs Q2 2014
Gross Profit$90,101,000+10.1%
Operating Income$34,923,000+18.4%
Operating Cash Flowderived$35,645,000+6.2%
Free Cash Flowderived$32,217,000+14.9%
Margins · derived
Gross margin76.5%+0.1 pt vs Q3 2013
Operating margin29.6%+2.1 pt vs Q3 2013
Net margin19.6%+0.6 pt vs Q3 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $117.79M | $107.19M | $94.76M | $84.27M |
| Net Income | $23.06M | $20.31M | $16.49M | $16.86M |
| EPS Diluted | $0.24 | $0.22 | $0.18 | $0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR